Close Menu

EPFL

SMiLE-seq combines antibody arrays, mechanical trapping, and next-generation sequencing readouts to provide a new platform for characterizing DNA-protein interactions.

NEW YORK (GenomeWeb News) – Swiss biochemical extraction company Spinomix has closed a Series A equity investment of $3 million, with the funds coming from existing and new investors, the company said today.

AB Sciex's new TripleTOF 5600 and Waters' new Xevo G2 QTof will enable researchers to run qualitative and quantitative workflows simultaneously, the companies said, allowing for full scans of complex samples that can then be interrogated in a more targeted fashion.

ISB researchers will use the company's synthetic peptides and HeavyPeptide AQUA standards in their efforts to develop selected-reaction monitoring and multiple-reaction monitoring mass spectrometry assays for each of the roughly 25,000 human proteins.

Two COVID-19 vaccine developers have released their trial protocols to build public trust, the New York Times reports.

A new analysis finds the rapid COVID-19 test from DnaNudge to be highly accurate, Reuters reports.

In Science this week: global citizens' assembly on genome-editing technologies proposed, epigenetic markers predict metformin response, and more.

According to the Verge, many US states are not including positive results from rapid COVID-19 testing in their case numbers.